Advances in Drug Research: Volume 26
Published on 5. September 1995
Book
Hardback
279 pages
978-0-12-013326-0 (ISBN)
Description
Volume 26 continues the trend of shorter, more frequent volumes. With Volume 25, the series gained a new co-editor, Urs Meyer. While retaining the commitment to publish chapters on therapeutic or chemical classes and on general topics or concepts, the series' coverage has expanded to include methodological chapters, and new areas of recognized or potential significance to drug research, especially in molecular pharmacology.
More details
Series
Language
English
Place of publication
San Diego
United States
Publishing group
Elsevier Science Publishing Co Inc
Target group
Professional and scholarly
Dimensions
Height: 229 mm
Width: 152 mm
Weight
530 gr
ISBN-13
978-0-12-013326-0 (9780120133260)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Persons
Content
L.B. Kier and B. Testa, Complexity and Emergence in Drug Research.
M.S. Tute, Drug Design: the Present and the Future.
K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools.
C.L. Crespi, Xenobiotic-metabolizing Human Cells as Tools for Pharmacological and Toxicological Research.
J. Urquhart, Correlates of Variable Patient Compliance in Drug Trials: Relevance in the New Health Care Environment.
Subject Index.
Cumulative Index of Authors.
Cumulative Index of Titles.
M.S. Tute, Drug Design: the Present and the Future.
K. Burki and B. Ledermann, Transgenic Animals as Pharmacological Tools.
C.L. Crespi, Xenobiotic-metabolizing Human Cells as Tools for Pharmacological and Toxicological Research.
J. Urquhart, Correlates of Variable Patient Compliance in Drug Trials: Relevance in the New Health Care Environment.
Subject Index.
Cumulative Index of Authors.
Cumulative Index of Titles.